title: Myeloablative conditioning for hematopoietic stem-cell transplantation in patients with non-malignant diseases.
authors.forename: O
authors.initials: O
authors.lastname: Ringdén
authors.forename: P
authors.initials: P
authors.lastname: Svenberg
authors.forename: K
authors.initials: K
authors.lastname: Le Blanc
authors.forename: J
authors.initials: J
authors.lastname: Mattsson
authors.forename: M
authors.initials: M
authors.lastname: Remberger
mesh_terms: D004305:Dose-Response Relationship, Drug; D018380:Hematopoietic Stem Cell Transplantation / Q000379:methods* / Q000401:mortality; D006801:Humans; D019653:Myeloablative Agonists / Q000627:therapeutic use; D016019:Survival Analysis; D019172:Transplantation Conditioning / Q000379:methods*
chemical_list: D019653:Myeloablative Agonists